{"id":54040,"date":"2025-12-23T13:33:17","date_gmt":"2025-12-23T13:33:17","guid":{"rendered":"https:\/\/my.legal500.com\/developments\/?post_type=press_releases&#038;p=54040"},"modified":"2025-12-23T13:33:17","modified_gmt":"2025-12-23T13:33:17","slug":"homburger-advises-windward-bio-on-licensing-deal-with-qyuns-therapeutics","status":"publish","type":"press_releases","link":"https:\/\/my.legal500.com\/developments\/press-releases\/homburger-advises-windward-bio-on-licensing-deal-with-qyuns-therapeutics\/","title":{"rendered":"Homburger advises Windward Bio on licensing deal with Qyuns Therapeutics"},"content":{"rendered":"<p><strong>On December 21, 2025, Windward Bio Group AG, a Swiss-based private, clinical-stage biotechnology company committed to improving outcomes for people living with advanced immunological diseases, announced a licensing agreement between its affiliate, LE2025 Therapeutics AG, and Qyuns Therapeutics Co., Ltd. for the development and commercialization of WIN027 (also known as QX027N), a potential best-in-disease, long-acting bispecific antibody targeting TSLP and IL-13.<\/strong><\/p>\n<p><!--more--><\/p>\n<p>Under the terms of the agreement, Windward Bio will gain exclusive rights to develop, manufacture, and commercialize WIN027 outside of China, for a total of up to USD 700 m in upfront and equity consideration and development and commercial milestones, as well as tiered royalties.<\/p>\n<p>The Homburger team advising Windward Bio includes Andreas M\u00fcller, Margrit Marti, Timo Hasler and Lucas Forrer (all Healthcare \/ Life Sciences and Corporate \/ M&amp;A), Stefan Oesterhelt and Juliette Buob (both Tax) and other subject matter specialists.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Contact<br \/>\n<\/strong>Gloria P\u00fcnchera \/ Marketing \/ <a href=\"mailto:marketing@homburger.ch\">marketing@homburger.ch<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-54040","press_releases","type-press_releases","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases\/54040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/types\/press_releases"}],"wp:attachment":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/media?parent=54040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}